Vanda Pharmaceuticals Inc. (VNDA) is a publicly traded Healthcare sector company. As of May 21, 2026, VNDA trades at $6.30 with a market cap of $365.62M and a P/E ratio of -1.52. VNDA moved +2.92% today. Year to date, VNDA is -21.47%; over the trailing twelve months it is +39.19%. Its 52-week range spans $3.81 to $9.94. Analyst consensus is strong buy with an average price target of $16.75. Rallies surfaces VNDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Vanda Pharmaceuticals Inc. (VNDA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VNDA moved +2.92% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $6.30 |
| Market Cap | $365.62M |
| P/E Ratio | -1.52 |
| EPS | $-4.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.94 |
| 52-Week Low | $3.81 |
| Volume | 594 |
| Avg Volume | 0 |
| Revenue (TTM) | $217.78M |
| Net Income | $-239.55M |
| Gross Margin | 0.00% |
4 analysts cover VNDA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.75.